Finnish Institute for Health and Welfare, Helsinki, Finland; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Finnish Institute for Health and Welfare, Helsinki, Finland.
Int J Infect Dis. 2023 Jun;131:1-6. doi: 10.1016/j.ijid.2023.03.026. Epub 2023 Mar 21.
The Puumala virus (PUUV) is a hantavirus that causes hemorrhagic fever with renal syndrome. Studies showing an increased risk of lymphoid malignancies after hantavirus infection, together with the observation that PUUV infects B cells, motivated us to study the risk of lymphoid malignancies after PUUV infection.
We linked data from the Finnish Cancer Registry and National Infectious Diseases Register for 2009-2019. We used a time-dependent Cox regression model to evaluate the hazard of the lymphoid malignancies grouped according to the HAEMACARE classification.
We identified 68 cases of lymphoid malignancies after PUUV infection among 16,075 PUUV-infected individuals during 61,114,826 person-years of observation. A total of 10 cases occurred within 3-<12 months and 38 within 1-<5 years after PUUV infection, and the risk of lymphoid malignancies increased with hazard ratios (HRs) of 2.0 (95% confidence interval [CI], 1.1-3.7) and 1.6 (95% CI, 1.2-2.3), respectively. The group of mature B cell neoplasms showed an increased risk 3-<12 months and 1-<5 years after PUUV infection, HR 2.2 (95% CI, 1.2-4.3) and HR 1.8 (95% CI, 1.3-2.5), respectively.
PUUV infection is associated with lymphoid malignancies in the Finnish population, supporting the earlier studies. Further research is required to understand the pathophysiological mechanisms behind this association.
普马拉病毒(PUUV)是一种汉坦病毒,可引起肾综合征出血热。研究表明,汉坦病毒感染后恶性淋巴瘤的风险增加,同时观察到 PUUV 感染 B 细胞,这促使我们研究 PUUV 感染后恶性淋巴瘤的风险。
我们将 2009 年至 2019 年芬兰癌症登记处和国家传染病登记处的数据进行了关联。我们使用时依 Cox 回归模型来评估根据 HAEMACARE 分类的恶性淋巴瘤的危险比。
在 61,114,826 人年的观察期间,在 16,075 例 PUUV 感染个体中发现了 68 例感染后发生的恶性淋巴瘤。总共 10 例发生在感染后 3-<12 个月,38 例发生在感染后 1-<5 年,恶性淋巴瘤的风险增加,危险比(HRs)分别为 2.0(95%置信区间[CI],1.1-3.7)和 1.6(95%CI,1.2-2.3)。成熟 B 细胞肿瘤组在感染后 3-<12 个月和 1-<5 年内的风险增加,HR 分别为 2.2(95%CI,1.2-4.3)和 HR 1.8(95%CI,1.3-2.5)。
在芬兰人群中,PUUV 感染与恶性淋巴瘤相关,支持早期研究。需要进一步研究以了解这种关联背后的病理生理机制。